Taken together, NEP inhibitors have beneficial effects on glucose homeostasis and insulin sensitivity by increasing various substrates including GLP‐1 and thus, could be effective alone or in combination with antidiabetic agents in treating T2DM patients. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.